(Q44633755)

English

Comparison of lunch and bedtime NPH insulin plus mealtime insulin Lispro therapy with premeal regular insulin plus bedtime NPH insulin therapy in type 2 diabetes

scientific article published on November 1, 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Comparison of lunch and bedtime NPH insulin plus mealtime insulin Lispro therapy with premeal regular insulin plus bedtime NPH insulin therapy in type 2 diabetes (English)

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

type 2 diabetes

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

insulin therapy

1 reference

based on heuristic

inferred from title

regular insulin

1 reference

based on heuristic

inferred from title

1 reference

10.1016/S0168-8227(03)00167-0

https://api.crossref.org/works/10.1016/S0168-8227(03)00167-0

25 March 2024

internal medicine

1 reference

10.1016/S0168-8227(03)00167-0

https://api.crossref.org/works/10.1016/S0168-8227(03)00167-0

25 March 2024

6

object named as

Selçuk Seber

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14581144

25 March 2024

author name string

Haluk Sargin

1

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Mehmet Sargin

2

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Yüksel Altuntaş

3

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Ekrem Orbay

5

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Sema Uçak

7

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Ali Yayla

8

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Ahmet M. Sengül

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14581144

25 March 2024

language of work or name

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14581144

25 March 2024

publication date

1 November 2003

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

full work available at URL

https://api.elsevier.com/content/article/PII:S0168822703001670?httpAccept=text/xml

1 reference

10.1016/S0168-8227(03)00167-0

https://api.crossref.org/works/10.1016/S0168-8227(03)00167-0

25 March 2024

https://api.elsevier.com/content/article/PII:S0168822703001670?httpAccept=text/plain

1 reference

10.1016/S0168-8227(03)00167-0

https://api.crossref.org/works/10.1016/S0168-8227(03)00167-0

25 March 2024

Diabetes Research and Clinical Practice

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

62

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

79-86

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Nonfasting plasma glucose is a better marker of diabetic control than fasting plasma glucose in type 2 diabetes.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2803%2900167-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Glucose tolerance and mortality: comparison of WHO and American Diabetic Association diagnostic criteria

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2803%2900167-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Glucose tolerance and cardiovascular mortality: comparison of fasting and 2-hour diagnostic criteria

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2803%2900167-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Risk factors for myocardial infarction and death in newly detected NIDDM: the Diabetes Intervention Study, 11-year follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2803%2900167-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Therapy focused on lowering postprandial glucose, not fasting glucose, may be superior for lowering HbA1c. IOEZ Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2803%2900167-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Is HbA(1c) influenced more strongly by preprandial or postprandial glycemia in type 1 diabetes?

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2803%2900167-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Plasma glucose levels throughout the day and HbA(1c) interrelationships in type 2 diabetes: implications for treatment and monitoring of metabolic control

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2803%2900167-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Insulin analogues and their potential in the management of diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2803%2900167-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Mealtime treatment with insulin analog improves postprandial hyperglycemia and hypoglycemia in patients with non-insulin-dependent diabetes mellitus. Multicenter Insulin Lispro Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2803%2900167-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2803%2900167-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of the insulin analogue [LYS(B28),PRO(B29)] on blood glucose control

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2803%2900167-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Intramuscular injection of insulin lispro or soluble human insulin: pharmacokinetics and glucodynamics in Type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2803%2900167-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Time-action profile of the insulin analogue B28Asp

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2803%2900167-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Insulin lispro.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2803%2900167-0

7 January 2021

based on heuristic

inferred from DOI database lookup

The impact of the diabetes control and complications trial and humalog insulin on glycohemoglobin levels and severe hypoglycemia in type 1 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2803%2900167-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Evaluating once- and twice-daily self-monitored blood glucose testing strategies for stable insulin-treated patients with type 2 diabetes : the diabetes outcomes in veterans study

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2803%2900167-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Does insulin lispro preserve the physiological defences to hypoglycaemia during intensive insulin therapy with a conventional basal bolus regimen?

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2803%2900167-0

7 January 2021

based on heuristic

inferred from DOI database lookup

A comparative study of insulin lispro and human regular insulin in patients with type 2 diabetes mellitus and secondary failure of oral hypoglycemic agents

12

1 reference

10.1016/S0168-8227(03)00167-0

https://api.crossref.org/works/10.1016/S0168-8227(03)00167-0

25 March 2024

Improved glycaemic control with the use of self-prepared mixtures of insulin lispro and insulin lispro protamine suspension in patients with types 1 and 2 diabetes

18

1 reference

10.1016/S0168-8227(03)00167-0

https://api.crossref.org/works/10.1016/S0168-8227(03)00167-0

25 March 2024

Identifiers

10.1016/S0168-8227(03)00167-0

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44633755&oldid=2110707296"